Dr Kade acquires herbal portfolio from Hexal

17 January 2017 - Deborah Wilkes

Archived

Germany's Dr Kade has acquired a portfolio of herbal products from Hexal – including Femikliman for menopausal women and Silicur for protecting the liver – for an undisclosed sum.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: